Literature DB >> 33355468

Comprehensive Characterization of APTES Surface Modifications of Hydrous Boehmite Nanoparticles.

Ajmal Zarinwall1, Tassilo Waniek2, Reza Saadat1, Ulrike Braun2, Heinz Sturm2, Georg Garnweitner1.   

Abstract

Hydrous boehmite-AlOOH) nanoparticles (BNP) show great potential as nanoscale filler for the fabrication of fiber reinforced nanocomposite materials. Notably, the particle-matrix interaction has been demonstrated to be decisive for improving the matrix-dominant mechanical properties in the past years. Tailoring the surface properties of the nanofiller enables to selectively design the interaction and thus to exploit the benefits of the nanocomposite in an optimal way. Here, an extensive study is presented on the binding of (3-aminopropyl)triethoxysilane (APTES), a common silane surface modifier, on BNP in correlation to different process parameters (concentration, time, temperature, and pH). Furthermore, a comprehensive characterization of the modified BNP was performed by using elemental analysis (EA), thermogravimetric analysis (TGA) coupled with mass spectrometry (TGA-MS), and Kaiser's test (KT). The results show an increasing monolayer formation up to a complete surface coverage with rising APTES concentration, time, and temperature, resulting in a maximal grafting density of 1.3 molecules/nm2. Unspecific multilayer formation was solely observed under acidic conditions. Comparison of TGA-MS results with data recorded from EA, TGA, and KT verified that TGA-MS is a convenient and highly suitable method to elucidate the ligand binding in detail.

Entities:  

Year:  2020        PMID: 33355468     DOI: 10.1021/acs.langmuir.0c02682

Source DB:  PubMed          Journal:  Langmuir        ISSN: 0743-7463            Impact factor:   3.882


  1 in total

1.  Amorphization and modified release of ibuprofen by post-synthetic and solvent-free loading into tailored silica aerogels.

Authors:  Ajmal Zarinwall; Viktor Maurer; Jennifer Pierick; Victor Marcus Oldhues; Julian Cedric Porsiel; Jan Henrik Finke; Georg Garnweitner
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.819

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.